Alaska Medical Assistance: State Fiscal Year 2027 Fee Schedule — CHA/P Services
Customize your policy alerts
Sign up for all Alaska Medicaid policy alerts
Know when Alaska Medicaid releases new policies or updates existing guidance.
Monitor payer policy activity
Fee schedule governing reimbursement rates and covered CPT/HCPCS procedure codes for Community Health Aide/Practitioner (CHA/P) services under Alaska Medicaid for the State Fiscal Year 2027; applies to providers billing CHPs and participating Tribal Health Organizations. Partial document (part 1 of 9).
No material clinical or coverage changes in this revision.
Coverage notes and indicators
Reimbursement and administrative notes
Reimbursement approach and administrative notice
Extract-level coverage notes
No explicit coverage criteria are stated in these fee-schedule rows; the entries list procedure codes with category column indicators.
Procedure coverage/indicator matrix (partial)
Matrix-style indicators showing per-code applicability across CHA I–IV and CHP columns.
Tabular code allowance — excerpt
Observed coverage markers and listed procedure codes (excerpt).
Coverage listing (partial)
Listed codes and associated matrix indicators (partial listing).
No explicit coverage criteria in excerpt
Partial fee-schedule listing — this excerpt does not contain explicit medical necessity criteria.
Coverage indicators and code equivalencies
Indicators and per-code equivalencies shown in preventive care and related listings.
Coverage stance for listed codes
Coverage stance for listed codes in this excerpt: per-line payment/availability markers only.
CPT / HCPCS codes in this excerpt
| 29130 | Application of splint |
| 96366 | Therapeutic/prophylactic/diagnostic IV infusion add-on |
| 96372 | Therapeutic/prophylactic/diagnostic injection SC/IM |
| 96374 | Therapeutic/prophylactic/diagnostic injection IV push |
| 96375 | Therapeutic/prophylactic/diagnostic injection new drug add-on |
| 99050 | Medical services after hours |
| 99173 | Visual acuity screen |
| 99202 | Office/outpatient new, straightforward/15 min |
| 99203 | Office/outpatient new, low/30 min |
| 99204 | Office/outpatient new, moderate/45 min |
| 99205 | Office/outpatient new, high/60 min |
| 99344 | Home/resident visit new, moderate MDM 60 |
| 99345 | Home/resident visit new, high MDM 75 |
| 99347 | Home/resident visit established, straightforward MDM |
| 99348 | Home/resident visit established, low MDM |
| 99349 | Home/resident visit established, moderate MDM |
| 99381 | Initial preventive medicine E/M, new patient, infant |
| 99382 | Initial preventive medicine E/M, new patient, age 1-4 years |
| 99383 | Initial preventive medicine E/M, new patient, age 5-11 years |
| 99384 | Initial preventive medicine E/M, new patient, age 12-17 years |
| 99385 | Initial preventive medicine E/M, new patient, age 18-39 years |
| D0145 | Oral evaluation, patient <3 years |
| D1206 | Topical fluoride varnish |
| D1208 | Topical application fluoride, varnish |
| J0561 | Penicillin G benzathine injection |
| J0696 | Ceftriaxone sodium injection |
| J0885 | Epoetin alfa, non-ESRD |
| J1050 | Medroxyprogesterone acetate |
| J1438 | Etanercept injection |
| J1885 | Ketorolac tromethamine injection |
| J2550 | Promethazine HCl injection |
| J3420 | Vitamin B12 injection |
| J7030 | Normal saline solution infusion |
| J7040 | Normal saline solution infusion (alternate) |
| 29130 | Application of splint |
| 27197 | Procedure code listed in fee schedule extract |
| 27500 | Procedure code listed in fee schedule extract |
| 27508 | Procedure code listed in fee schedule extract |
| 27510 | Procedure code listed in fee schedule extract |
| 27750 | Procedure code listed in fee schedule extract |
| 28400 | Procedure code listed in fee schedule extract |
| 96366 | Ther/Proph/Diag IV infusion add-on |
| 96372 | Ther/Proph/Diag injection SC/IM |
| 96374 | Ther/Proph/Diag injection IV push |
| 96375 | Ther/Proph/Diag injection new drug add-on |
| 99050 | Medical services after hours |
| 99173 | Visual acuity screen |
| 99202 | Office/outpatient new SF 15 min |
| 99203 | Office/outpatient new low 30 min |
| 99204 | Office/outpatient new mod 45 min |
| 99205 | Office/outpatient new hi 60 min |
| 99344 | Home/resident visit new, moderate MDM 60 |
| 99345 | Home/resident visit new, high MDM 75 |
| 99347 | Home/resident visit established, straightforward MDM 20 |
| 99348 | Home/resident visit established, low MDM 30 |
| 99349 | Home/resident visit established, moderate MDM 40 |
| 99381 | Initial preventive medicine E/M new patient infant |
| 99382 | Initial preventive medicine E/M new patient 1-4 yrs |
| 99383 | Initial preventive medicine E/M new patient 5-11 yrs |
| 99384 | Initial preventive medicine E/M new patient 12-17 yrs |
| 99385 | Initial preventive medicine E/M new patient 18-39 yrs |
| D0145 | Oral evaluation, patient <3 years |
| D1206 | Topical fluoride varnish |
| D1208 | Topical application fluoride—varnish |
| J0561 | Penicillin G benzathine injection |
| J0696 | Ceftriaxone sodium injection |
| J0885 | Epoetin alfa, non-ESRD |
| J1050 | Medroxyprogesterone acetate |
| J1438 | Etanercept injection |
| J1885 | Ketorolac tromethamine injection |
| J2550 | Promethazine HCl injection |
| J3420 | Vitamin B12 injection |
| J7030 | Normal saline solution infusion |
| J7040 | Normal saline solution infusion (alternate) |
| 99344 | Home/resident visit new mod MDM 60 |
| 99345 | Home/resident visit new high MDM 75 |
| 99347 | Home/resident visit est SF MDM 20 |
| 99348 | Home/resident visit est low MDM 30 |
| 99349 | Home/resident visit est mod MDM 40 |
| 99381 | Init PM E/M new patient infant |
| 99382 | Init PM E/M new patient 1-4 yrs |
| 99383 | Prev visit new age 5-11 |
| 99384 | Prev visit new age 12-17 |
| 99385 | Prev visit new age 18-39 |
| D0145 | Oral evaluation, patient <3 years |
| D1206 | Topical fluoride varnish |
| D1208 | Topical fluoride application |
| J0561 | Penicillin G benzathine injection |
| J0696 | Ceftriaxone sodium injection |
| J0885 | Epoetin alfa, non-ESRD |
| J1050 | Medroxyprogesterone acetate |
| J1438 | Etanercept injection |
| J1885 | Ketorolac tromethamine injection |
| J2550 | Promethazine HCl injection |
| J3420 | Vitamin B12 injection |
| J7030 | Normal saline solution infusion |
| J7040 | Normal saline solution infusion |
Billing, reimbursement, and provider guidance
Reimbursement basis and provider notification
Reimbursement will follow the CHP (Community Health Program) encounter rate, as established annually by the Office of Rate Review (ORR) and distributed to Tribal Health Organizations and participating CHA/BHA providers. The fee schedule is subject to change; providers who identify potential errors or claim adjudication issues should contact the Division of Health Care Services for resolution.
- CHP encounter rate established annually by ORR and sent to THOs and participating CHA/BHAs.
- Coverage and rates are subject to change; clerical/typographical errors may be corrected promptly or at the next quarterly update.
Fee schedule listing — no authorization rules in extract
This excerpt shows fee-schedule rows listing CPT/HCPCS procedure codes alongside CHA/CHP category indicator columns, but it does not contain any prior authorization, denial risk, or explicit documentation/prior‑auth rules in the visible lines.
- Rows list procedure codes with CHA I–IV and CHP columns marked (e.g., 'X') to indicate applicability.
- No prior authorization, denial risk, or documentation instructions are shown in this extract.
Fee schedule matrix — indicator-only (no authorization guidance)
The table segment displays procedure codes with matrix-style coverage indicators (CHA I–IV, CHP) only; the excerpt does not include provider authorization guidance, denial criteria, documentation requirements, or step‑therapy rules.
- Matrix shows per-code 'X' and '=' markers under CHA/CHP columns to indicate allowance/relationship.
- No explicit provider action instructions (e.g., prior authorization) are present in this excerpt.
Coverage markers present in excerpt only
Codes in this excerpt are marked with 'X' (and occasionally '=') to indicate payment/allowance or grouping, but the visible pages do not include explicit prior authorization, denial risk, documentation, or step‑therapy rules.
- 'X' is used as the coverage/allowance indicator in the fee schedule table.
- Legend defining 'X'/'=' meaning is not present in this excerpt.
Vaccine code list (partial)
The fee schedule includes multiple influenza and related vaccine CPT codes in the vaccine rows; this excerpt lists vaccine codes with coverage indicators but does not add authorization instructions.
Procedure code list (partial)
Audiology and other procedure CPT codes are listed with per-column indicators in the fee schedule; the excerpt contains the code list but no authorization or special billing instructions in these lines.
Fee schedule excerpt — no authorization rules shown
This fee schedule excerpt lists procedure codes and grouping/bundling markers but does not include explicit prior authorization, denial-risk guidance, billing rules beyond indicator columns, or step‑therapy requirements in the visible lines.
- Rows show codes with 'X'/'=' markers (grouping/bundling) but no accompanying authorization or documentation rules.
- Providers should refer to the full fee schedule or program guidance for authorization and billing requirements not shown here.
May require physician or qualified health professional
Certain office/outpatient established visit codes may require a physician or qualified health professional; the listing shows the note 'OFF/OP EST MAY X REQ PHY/QHP'.
- Example: 99211 OFF/OP EST MAY X REQ PHY/QHP — indicates established visit may require physician/QHP involvement as marked.
Billing rule — use fee schedule codes and CHP encounter rate
Bill using the CPT/HCPCS codes listed and the fee‑schedule matrix indicators; the schedule notes rates are subject to change and that the CHP encounter rate governs reimbursement. Contact Division of Health Care Services for discrepancies.
- Use listed CPT/HCPCS codes as shown in the fee schedule rows when submitting claims.
- Reimbursement follows the CHP encounter rate established by ORR; coverage and rates are subject to change.
Fee schedule code entries — indicators and short descriptors
The fee schedule lists many individual code entries showing payment/availability indicators and short descriptors (for example, preventive counseling and digital E/M service lines), but the excerpted entries do not display dollar amounts or explicit claim submission instructions.
- Entries include codes such as 99421–99423 and descriptive labels (e.g., PREV MED CNSL INDIV APPRX 45 = OL DIG E/M SVC 11-20 MIN).
- Per-code 'X' indicators appear across CHA/CHP columns; fee amounts are not shown in this excerpt.
Preventive counseling codes (G-codes)
Preventive counseling and immunization counseling G-codes are listed with 'X' indicators (coverage/availability) in the fee schedule; the excerpt shows those codes but does not attach authorization conditions in the visible lines.
- Examples: G0312–G0315 (immunization counseling by a physician) and G0443 (brief alcohol misuse counseling) are listed with 'X' indicators.
- These G-codes are presented under the PREV MED CNSL INDIV APPRX 45 heading in the excerpt.
Drug and infusion supply codes (J‑codes)
J‑codes for injectable drugs and infusion supplies are listed with 'X' indicators in the preventive‑counseling rows; entries include many drug and infusion supply HCPCS codes but the excerpt does not include separate billing or prior‑authorization instructions.
Terms & matrix key
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.